TSE:4967Personal Products
Assessing Kobayashi Pharmaceutical (TSE:4967) Valuation After Governance Proposals And Product Incident
Why the latest governance proposals matter for shareholders
A shareholder proposal targeting governance reforms at Kobayashi Pharmaceutical (TSE:4967) has put the upcoming March 27 AGM in focus, as the Board opposes all four Oasis Japan Strategic Fund items.
See our latest analysis for Kobayashi Pharmaceutical.
The shareholder proposals appear to have sharpened interest in Kobayashi Pharmaceutical, with the share price at ¥5,506 and a 7 day share price return of 3.95%. This comes even as the...